Provided by Tiger Fintech (Singapore) Pte. Ltd.

Haemonetics

49.44
-0.9200-1.83%
Volume:483.25K
Turnover:24.01M
Market Cap:2.38B
PE:15.09
High:50.78
Open:50.00
Low:48.98
Close:50.36
52wk High:94.99
52wk Low:47.32
Shares:48.18M
Float Shares:47.60M
Volume Ratio:1.18
T/O Rate:1.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.28
EPS(LYR):3.33
ROE:18.27%
ROA:6.52%
PB:2.70
PE(LYR):14.84

Loading ...

Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jul 25, 2025

Major Issues Report

Form 8-K - Current report
Jun 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 21, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2025

Major Issues Report

Form 8-K - Current report
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Feb 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 06, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 03, 2025

Major Issues Report

Form 8-K - Current report
Dec 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]